Aggressive TB control can yield big economic gains A fresh World Bank research survey discovers that 22 countries with the world’s highest amounts of TB cases could earn significantly more than they devote to TB medical diagnosis and treatment if indeed they signed onto a worldwide plan to sharply reduce the numbers of TB-related deaths. Highly affected African countries could gain up to nine times their investments in TB control. The analysis also warns about the need to step up TB control worldwide with the growing emergence of multidrug-resistant TB and extensively drug-resistant TB in southern Africa, eastern European countries and Central Asia More information here .
And overseas, to allow us to offer our gadget to the doctors’ offices and clinics, so doctors can simply monitor the performance or resistance of anti-platelet drugs. President & COO Robert C. Hux, CPA, added, The funds we raised allows us to staff up to total the product advancement, prepare the FDA filings, and begin offering the AggreGuide worldwide. .. Aggredyne closes $3 million Series A convertible preferred stock financing Aggredyne, Inc., a Houston-based biomedical diagnostics business that is defining a fresh standard for platelet function tests, sold out and closed a $3 million Series A convertible recommended stock financing. Aggredyne is also preparing to file with the meals and Medication Administration a 510 for clearance to advertise its initial item, the AggreGuideTM A-100, and related bloodstream platelet assessment.